Research Roundup: Lassa vaccine trial, Visceral leishmaniasis project, WHO PQ for HIV test
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
The World Health Organization's (WHO's) prequalification program is a key actor in the global health ecosystem and an important driver of expanding product access, but despite recently announced improvements to make the program more efficient and transparent, structural challenges continue to undermine its capacity to play a transformative role in quickly accelerating access to a whole spectrum of health products, especially novel technologies, in low- and middle-income countries.